Barely Significant
← all excerpts

Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.

J Am Heart Assoc · 2016 · PMC5015410 · PMID 27413042

Europe PMCDOI
1
hedged sentence
0.5600
closest p · 11.2× alpha
0.5600
boldest claim

The sentences

did not reach statistical significanceP =0.56not close (p > 0.1)
Similar magnitudes of effect were observed among the rosuvastatin subgroup, although the associations did not reach statistical significance; corresponding P linear trend were 0.64 and 0.38 while HRs per SD of GlycA were 1.07 (95% CI, 0.86–1.33; P =0.56) and 1.06 (95% CI, 0.82–1.37; P =0.67), respectively.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.